Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1

AIDS Research and Human Retroviruses

Volumn 15, Issue 11, 1999, Pages 989-1000

  Hibbitts, Sam ^a,b   Reeves, Jacqueline D ^a,b   Simmons, Graham ^a,b   Gray, Patrick W ^c   Epstein, Leon G ^d   Schols, Dominique ^e   De Clercq, Erik ^e   Wells, Timothy N C ^f   Proudfoot, Amanda E I ^f   Clapham, Paul R ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^f SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

ANTI-HIV AGENTS; BRAIN; CELLS, CULTURED; CHEMOKINES; HIV-1; HUMANS; LIGANDS; MICROGLIA; RANTES; RECEPTORS, CCR5; RECEPTORS, CXCR4;

EID: 0033587504     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310502     Document Type: Article

References (86)

1. Resnick L, Berger JR, Shapshak P, and Tourtellotte WW: Early penetration of the blood-brain barrier by HIV. Neurology 1988;38:9-14.
2. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, and Wiley CA: Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992;42:1736-1739.
3. An SF and Scaravilli F: Early HIV-1 infection of the central nervous system. Arch Anat Cytol Pathol 1997;45:94-105.
4. Vazeux R, Brousse N, Jarry A, Henin D, Marche C, Vedrenne C, Mikol J, Wolff M, Michon C, Rozenbaum W, Bureau J-F, Montagnier L, and Brahic M: AIDS subacute encephalitis. Identification of HTV-infected cells. Am J Pathol 1987;126:403-410.
5. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, and Fauci AS: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233:1089-1093.
6. Sharer LR, Saito Y, Epstein LG, and Blumberg BM: Detection of HIV-1 DNA in pediatric AIDS brain tissue by two-step ISPCR. Adv Neuroimmunol 1994;4:283-285.
7. Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich TA, and Blumberg BM: Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in post-mortem pediatric central nervous tissues. Neurology 1994;44: 474-481.
8. Wiley CA, Schrier RD, Nelson JA, Lampert PW, and Oldstone MB: Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-7093.
9. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, and Fauci AS: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233:1089-1093.
10. Nottet HS and Gendelman HE: Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol. Today 1995;16:441-448.
11. Giulian D, Vaca K, and Noonan CA; Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 250:1593-1596.
12. Power C, McArthur JC, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson RT, and Chesebro B: Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented patients. J Virol 1998;72:9045-9053.
13. Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J, and Gabuzda D: Apoptosis induced by HTV-1 infection of the central nervous system. J Clin Invest 1996;98:1979-1990.
14. Weiss RA: Cellular receptors and viral glycoproteins involved in retrovirus entry. In: The Retroviridae, Vol. 2 (Levy JA, ed.). Plenum Press, New York, 1993.
15. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, and Hendrickson WA: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature (London) 1998;393:648-659.
16. Rizzuto CD, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WA, and Sodroski J: A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998;280:1949-1953.
17. Clapham PR and Weiss RA: Immunodeficiency viruses. Spoilt for choice of co-receptors. Nature (London) 1997;388:230-231.
18. Rucker J, Edinger AL, Sharron M, Samson M, Lee B, Berson JF, Yi Y, Margulies B, Collman RG, Doranz BJ, Parmentier M, and Doms RW: Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 1997;71:8999-9007.
19. Choe H, Farzan M, Konkel M, Martin K, Sun Y, Marcon L, Cayabyab M, Berman M, Dorf ME, Gerard N, Gerard C, and Sodroski J: The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J Virol 1998;72:6113-6118.
20. Samson M, Edinger AL, Stordeur P, Rucker J, Verhasselt V, Sharron M, Govaerts C, Mollereau C, Vassart G, Doms RW, and Parmentier M: ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HTV-1 strains. Eur J Immunol 1998;28:1689-1700.
21. Clapham PR: HTV and chemokines: Ligands sharing cell-surface receptors. Trends Cell Biol 1997;7:264-268.
22. Berger EA: HIV entry and tropism: The chemokine receptor connection. AIDS 1997;11:S3-S16.
23. Moore JP, Trkola A, and Dragic T: Co-receptors for HIV-1 entry. Curr Opin Immunol 1997;9:551-562.
24. Doranz BJ, Berson JF, Rucker J, and Doms RW: Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1). Immunol Res 1997;16:15-28.
25. Bleul CC, Wu L, Hoxie JA, Springer TA, and Mackay CR: The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-1930.
26. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, and Mackay CR: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185: 1681-1691.
27. McKnight A, Wilkinson D, Simmons G, Talbot S, Picard L, Ahuja M, Marsh M, Hoxie JA, and Clapham PR: Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol 1997;71:1692-1696.
28. Simmons G, Reeves JD, McKnight A, Dejucq N, Hibbitts S, Power CA, Aarons E, Schols D, Clercq ED, Proudfoot AEI, and Clapham PR: CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol 1998;72:8453-8457.
29. Di Marzio P, Tse J, and Landau NR: Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. AIDS Res Hum Retroviruses 1998;14:129-138.
30. Yi Y, Rana S, Turner JD, Gaddis N, and Collman RG: CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol 1998;72:772-777.
31. Naif HM, Li S, Alali M, Sloane A, Wu L, Kelly M, Lynch G, Lloyd A, and Cunningham AL: CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol 1998;72:830-836.
32. Zaitseva M, Blauvelt A, Lee S, Lapham CK, Klaus-Kovtun V, Mostowski H, Manischewitz J, and Golding H: Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection. Nature Med 1997;3:1369-1375.
33. Valentin A, Albert J, Fenyö EM, and Åsjö B: Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J Virol 1994; 68:6684-6689.
34. Simmons G, Wilkinson D, Reeves JD, Dittmar MT, Beddows S, Weber J, Carnegi G, Desselberger U, Gray PW, Weiss RA, and Clapham PR: Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996;70: 8355-8360.
35. Schuitemaker H, Kootstra NA, de Goede RE, de Wolf F, Miedema F, and Tersmette M: Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HTV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 1991;65:356-363.
36. Connor RI, Paxton WA, Sheridan KE, and Koup RA: Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1. J Virol 1996; 70:8758-8764.
37. Karita E, Nkengasong JN, Willems B, Vanham G, Fransen K, Heyndrickx L, Janssens W, Piot P, and van der Groen G: Macrophage-tropism of HIV-1 isolates of different genetic sub-types. AIDS 1997;11:1303-1304.
38. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, and Gabuzda D: CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (London) 1997;385:645-649.
39. Shieh JT, Albright AV, Sharron M, Gartner S, Strizki J, Doms RW, and Gonzalez Scarano F: Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J Virol 1998;72:4243-4249.
40. Ghorpade A, Xia MQ, Hyman BT, Persidsky Y, Nukuna A, Bock P, Che M, Limoges J, Gendelman HE, and Mackay CR: Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J Virol 1998;72:3351-3361.
41. Proudfoot AEI, Wells TNC, and Clapham PR: Chemokine receptors - future therapeutic targets for HIV? Biochem Pharmacol 1999;57:451-463.
42. Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TNC, and Proudfoot AE: Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 1997;276:276-279.
43. Schols D, Struyf S, Van Damme J, Este JA, Henson G, and De Clercq E: Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997; 186:1383-1388.
44. Schols D, Este JA, Henson G, and De Clercq E: Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. Antiviral Res 1997;35:147-156.
45. Deng HK, Unutmaz D, KewalRamani VN, and Littman DR: Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature (London) 1997;388:296-300.
46. Simmons G, McKnight A, Takeuchi Y, Hoshino H, and Clapham PR: Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: A V3 loop-determined restriction. Virology 1995;209:696-700.
47. Cheng Mayer C, Weiss C, Seto D, and Levy JA: Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc Natl Acad Sci USA 1989; 86:8575-8579.
48. Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, Nathanson N, and Srinivasan A: An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 1992;66:7517-7521.
49. Doms RW, Edinger AL, and Moore JR: Coreceptor use by primate lentiviruses. The Human Retroviruses and AIDS 1998 Compendium. http://hiv-web.lanl.gov/ HTML/reviews/Doms98.html.
50. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, and Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986;59:284-291.
51. Bleul CC, Farzan M, Choe H, Parolin C, Clark Lewis I, Sodroski J, and Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (London) 1996;382:829-833.
52. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana Seisdedos F, Schwartz O, Heard JM, Clark Lewis I, Legier DF, Loetscher M, Baggiolini M, and Moser B: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (London) 1996; 382:833-835.
53. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85: 1135-1148.
54. Cocchi F, DeVico AL, Garzino Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
55. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, Moore PS, Chang Y, and Weiss RA: Angiogenic and HTV-inhibitory functions of KSHV-encoded chemokines. Science 1997;278:290-294.
56. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Luttichau HR, Gerstoft J, Clapham PR, dark Lewis I, Wells TNC, and Schwartz TW: A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 1997;277:1656-1659.
57. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, De Clercq E, and Moore JP: AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nature Med 1998;4:72-77.
58. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, and Schall TJ: A new class of membranebound chemokine with a CX3C motif. Nature (London) 1997; 385:640-644.
59. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma J, Dussault B, Woolf E, Alperin G, Culpepper J, Gutierrez Ramos JC, and Gearing D: Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (London) 1997;387:611-617.
60. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, and Yoshie O: Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997;91:521-530.
61. Reeves JD, McKnight A, Potempa S, Simmons G, Gray PW, Power CA, Wells T, Weiss RA, and Talbot SJ: CD4-independent infection by HIV-2 (ROD/B): Use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 1997; 231:130-134.
62. Jiang Y, Salafranca MN, Adhikari S, Xia Y, Feng L, Sonntag MK, deFiebre CM, Pennell NA, Streit WJ, and Harrison JK: Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J Neuroimmunol 1998;86:1-12.
63. Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A, and Satoh M: Localization of fractalkine and CX3CR1 mRNAs in rat brain: Does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 1998; 429:167-172.
64. + cells from virus binding. J Exp Med 1990;172:1233-1242.
65. Clapham PR, McKnight A, and Weiss RA: Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: Induction and enhancement by soluble CD4. J Virol 1992;66:3531-3537.
66. McKeating JA, Thali M, Furman C, Karwowska S, Gorny MK, Cordell J, Zolla Pazner S, Sodroski J, and Weiss RA: Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. Virology 1992;190:134-142.
67. Freed EO, Englund G, and Martin MA: Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol 1995;69:3949-3954.
68. Schmidtmayerova H, Alfano M, Nuovo G, and Bukrinsky M: Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4-and CXCR4-mediated pathway: Replication is restricted at a postentry level. J Virol 1998;72:4633-4642.
69. Micklem K, Rigney E, Cordell J, Simmons D, Stross P, Turley H, Seed B, and Mason D: A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies. Br J Haematol 1989;73:6-11.
70. Raff MC, Fields KL, Hakomori SI, Mirsky R, Pruss RM, and Winter J: Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res 1979;174:283-308.
71. Ulvestad E, Williams K, Mork S, Antel J, and Nyland H: Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J Neuropathol Exp Neurol 1994;53:492-501.
72. Lee SC, Liu W, Brosnan CF, and Dickson DW: Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab Invest 1992;67:465-476.
73. Neumann M, Felber BK, Kleinschmidt A, Froese B, Erfle V, Pavlakis GN, and Brack Werner R: Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol 1995;69:2159-2167.
74. Liestoel K, Goplen AK, Dunlop O, Bruun JN, and Moehlen J: Kaposi's sarcoma and protection from HIV dementia. Science 1998;280:361-362.
75. Baldeweg T, Catalan J, Gazzard BG, Weiss RA, and Boshoff C: Kaposi's sarcoma and protection from HIV dementia. Science 1998;280:362.
76. Ghorpade A, Nukuna A, Che M, Haggerty S, Persidsky Y, Carter E, Carhart L, Shafer L, and Gendelman HE: Human immunodeficiency virus neurotropism: An analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J Virol 1998;72:3340-3350.
77. Strizki JM, Albright AV, Sheng H, M OC, Perrin L, and Gonzalez Scarano F: Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: Evidence of differential tropism. J Virol 1996;70: 7654-7662.
78. Dittmar MT, Simmons G, Donaldson Y, Simmonds P, Clapham PR, Schulz TF, and Weiss RA: Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR. J Virol 1997; 71:5140-5147.
79. Di Stefano M, Gray F, Leitner T, and Chiodi F: Analysis of ENV V3 sequences from HIV-1-infected brain indicates restrained virus expression throughout the disease. J Med Virol 1996;49:41-48.
80. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, and Chesebro B: Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 1994;68:4643-4649.
81. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, and Arenzana Seisdedos F: HIV coreceptor downregulation as antiviral principle: SDF-1 alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997;186: 139-146.
82. Signoret N, Oldridge J, Pelchen Matthews A, Klasse PJ, Tran T, Brass LF, Rosenkilde MM, Schwartz TW, Holmes W, Dallas W, Luther MA, Wells TN, Hoxie JA, and Marsh M: Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol 1997;139:651-664.
83. Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Stangassinger M, Borlat F, Wells TN, Schlondorff D, and Proudfoot AE: Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity. J Exp Med 1998; 187: 1215-1224.
84. Stewart GJ, Ashton LJ, Biti RA, Ffrench RA, Bennetts BH, Newcombe NR, Benson EM, Carr A, Cooper DA, and Kaldor JM: Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group. AIDS 1997;11:1833-1838.
85. Eugen Olsen J, Iversen AK, Garred P, Koppelhus U, Pedersen C, Benfield TL, Sorensen AM, Katzenstein T, Dickmeiss E, Gerstoft J, Skinhoj P, Svejgaard A, Nielsen JO, and Hofmann B: Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997;11:305-310.
86. Benkirane M, Jin DY, Chun RF, Koup RA, and Jeang KT: Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5 delta32. J Biol Chem 1997;272:30603-30606.